[ Price : $8.95]
Federal Register notice: FDA renews its Allergenic Products Advisory Committee for an additional two years beyond the charter expi...[ Price : $8.95]
Federal Register notice: FDA determines that 50 listed drug products were not withdrawn for safety or effectiveness reasons.[ Price : $8.95]
The 2nd Circuit Court of Appeals says a New York federal court properly granted summary judgment to FDA and Sarepta in a Freedom o...[ Price : $8.95]
FDA says the Haimen Shengbang Laboratory Equipment recall of unapproved viral transport media containers is Class 1.[ Price : $8.95]
FDA attorney Heather Messick describes agency concerns with the European Union's General Data Protection Regulation.[ Price : $8.95]
FDA grants Attralus an orphan drug designation for 124 I-AT-01 iodine (evuzamitide) as a diagnostic for managing transthyretin amy...[ Price : $8.95]
FDA approves Myovant Sciences/Pfizers Myfembree (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) for managing m...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled "Q-Submissions Program for Medical Devi...